These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 6657694

  • 1. Effect of secondary hyperparathyroidism on the anaemia of end-stage renal failure: in vivo and in vitro studies.
    Grützmacher P, Radtke HW, Fassbinder W, Koch KM, Schoeppe W.
    Proc Eur Dial Transplant Assoc; 1983; 20():739-45. PubMed ID: 6657694
    [Abstract] [Full Text] [Related]

  • 2. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ, Wallin JD, Husserl F, Deftos LJ, Rice JC, O'Neill WJ, Fisher JW.
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [Abstract] [Full Text] [Related]

  • 3. Effect of parathyroidectomy on anemia in chronic renal failure.
    Barbour GL.
    Arch Intern Med; 1979 Aug; 139(8):889-91. PubMed ID: 464702
    [Abstract] [Full Text] [Related]

  • 4. Is anemia of chronic renal failure related to secondary hyperparathyroidism?
    Podjarny E, Rathaus M, Korzets Z, Blum M, Zevin D, Bernheim J.
    Arch Intern Med; 1981 Mar; 141(4):453-5. PubMed ID: 7212887
    [Abstract] [Full Text] [Related]

  • 5. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.
    Rao DS, Shih MS, Mohini R.
    N Engl J Med; 1993 Jan 21; 328(3):171-5. PubMed ID: 8417383
    [Abstract] [Full Text] [Related]

  • 6. [Increased in vitro and ex vivo proliferation of erythroid precursors induced by calcitriol in chronic renal failure. Synergistic effect with rHuEPO].
    Aucella F, Gatta G, Vigilante M, Scalzulli RP, Mantuano S, Carotenuto M, Stallone C.
    G Ital Nefrol; 2002 Jan 21; 19(2):137-42. PubMed ID: 12195411
    [Abstract] [Full Text] [Related]

  • 7. Anemia and secondary hyperparathyroidism.
    Zingraff J, Drüeke T, Marie P, Man NK, Jungers P, Bordier P.
    Arch Intern Med; 1978 Nov 21; 138(11):1650-2. PubMed ID: 718313
    [Abstract] [Full Text] [Related]

  • 8. Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism.
    Trunzo JA, McHenry CR, Schulak JA, Wilhelm SM.
    Surgery; 2008 Dec 21; 144(6):915-8; discussion 919. PubMed ID: 19040997
    [Abstract] [Full Text] [Related]

  • 9. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y, Inoue S, Horiguchi S, Kuki A.
    Miner Electrolyte Metab; 1995 Dec 21; 21(1-3):50-4. PubMed ID: 7565462
    [Abstract] [Full Text] [Related]

  • 10. Pathogenesis of anaemia in hyperparathyroidism.
    Sikole A.
    Med Hypotheses; 2000 Feb 21; 54(2):236-8. PubMed ID: 10790758
    [Abstract] [Full Text] [Related]

  • 11. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis.
    Chow TL, Chan TT, Ho YW, Lam SH.
    Arch Surg; 2007 Jul 21; 142(7):644-8. PubMed ID: 17638802
    [Abstract] [Full Text] [Related]

  • 12. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
    Biljanović-Paunović L, Djukanović L, Lezaić V, Stojanović N, Marisavljević D, Pavlović-Kentera V.
    Eur J Med Res; 1998 Dec 16; 3(12):564-70. PubMed ID: 9889177
    [Abstract] [Full Text] [Related]

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 16; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor I: a modulator of erythropoiesis in uraemic patients?
    Ureña P, Bonnardeaux A, Eckardt KU, Kurtz A, Drüeke TB.
    Nephrol Dial Transplant; 1992 Nov 16; 7(1):40-4. PubMed ID: 1316579
    [Abstract] [Full Text] [Related]

  • 15. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M, Dalva I, Yazicioğlu A, Akbay E, Cetin S.
    Int Urol Nephrol; 1993 Nov 16; 25(2):197-203. PubMed ID: 8365853
    [Abstract] [Full Text] [Related]

  • 16. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B, Grujić-Adanja G.
    Srp Arh Celok Lek; 1997 Nov 16; 125(5-6):163-7. PubMed ID: 9265238
    [Abstract] [Full Text] [Related]

  • 17. [The effect of subtotal parathyroidectomy in patients on haemodialysis].
    Vujić D, Majster Z, Lazić N, Radmirović A, Kekić Z.
    Srp Arh Celok Lek; 1994 Nov 16; 122(1-2):34-7. PubMed ID: 17972801
    [Abstract] [Full Text] [Related]

  • 18. [Indications and efficacy of parathyroidectomy in the treatment of secondary hyperparathyroidism in patients with chronic renal failure: our experience].
    Cotellese R, Mariano F, Costantini R, Francomano F, Napolitano L.
    Chir Ital; 2004 Nov 16; 56(1):47-53. PubMed ID: 15038647
    [Abstract] [Full Text] [Related]

  • 19. Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation.
    Drakopoulos S, Koukoulaki M, Apostolou T, Pistolas D, Balaska K, Gavriil S, Hadjiconstantinou V.
    Am J Surg; 2009 Aug 16; 198(2):178-83. PubMed ID: 19217601
    [Abstract] [Full Text] [Related]

  • 20. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L, Moreau-Gaudry X, Baron E, Cisterne JM, Monroziès-Bernadet P, Durand D.
    Clin Nephrol; 1997 Apr 16; 47(4):248-55. PubMed ID: 9128792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.